Correlation Between Intellipharmaceutics and OUTLOOK THERAPEUTICS

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Intellipharmaceutics and OUTLOOK THERAPEUTICS at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Intellipharmaceutics and OUTLOOK THERAPEUTICS into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Intellipharmaceutics International and OUTLOOK THERAPEUTICS INC, you can compare the effects of market volatilities on Intellipharmaceutics and OUTLOOK THERAPEUTICS and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Intellipharmaceutics with a short position of OUTLOOK THERAPEUTICS. Check out your portfolio center. Please also check ongoing floating volatility patterns of Intellipharmaceutics and OUTLOOK THERAPEUTICS.

Diversification Opportunities for Intellipharmaceutics and OUTLOOK THERAPEUTICS

0.1
  Correlation Coefficient

Average diversification

The 3 months correlation between Intellipharmaceutics and OUTLOOK is 0.1. Overlapping area represents the amount of risk that can be diversified away by holding Intellipharmaceutics Internati and OUTLOOK THERAPEUTICS INC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on OUTLOOK THERAPEUTICS INC and Intellipharmaceutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Intellipharmaceutics International are associated (or correlated) with OUTLOOK THERAPEUTICS. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of OUTLOOK THERAPEUTICS INC has no effect on the direction of Intellipharmaceutics i.e., Intellipharmaceutics and OUTLOOK THERAPEUTICS go up and down completely randomly.

Pair Corralation between Intellipharmaceutics and OUTLOOK THERAPEUTICS

If you would invest  3.80  in Intellipharmaceutics International on September 5, 2024 and sell it today you would earn a total of  0.00  from holding Intellipharmaceutics International or generate 0.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy4.55%
ValuesDaily Returns

Intellipharmaceutics Internati  vs.  OUTLOOK THERAPEUTICS INC

 Performance 
       Timeline  
Intellipharmaceutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Intellipharmaceutics International has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable forward indicators, Intellipharmaceutics is not utilizing all of its potentials. The newest stock price disturbance, may contribute to mid-run losses for the stockholders.
OUTLOOK THERAPEUTICS INC 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days OUTLOOK THERAPEUTICS INC has generated negative risk-adjusted returns adding no value to investors with long positions. Despite uncertain performance in the last few months, the Stock's essential indicators remain quite persistent which may send shares a bit higher in January 2025. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.

Intellipharmaceutics and OUTLOOK THERAPEUTICS Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Intellipharmaceutics and OUTLOOK THERAPEUTICS

The main advantage of trading using opposite Intellipharmaceutics and OUTLOOK THERAPEUTICS positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Intellipharmaceutics position performs unexpectedly, OUTLOOK THERAPEUTICS can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in OUTLOOK THERAPEUTICS will offset losses from the drop in OUTLOOK THERAPEUTICS's long position.
The idea behind Intellipharmaceutics International and OUTLOOK THERAPEUTICS INC pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.

Other Complementary Tools

Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Global Correlations
Find global opportunities by holding instruments from different markets
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA